Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of CAD 5.57 million. The enterprise value is 4.78 million.

Market Cap	5.57M
Enterprise Value	4.78M

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Avricore Health has 101.29 million shares outstanding. The number of shares has increased by 4.23% in one year.

Current Share Class	n/a
Shares Outstanding	101.29M
Shares Change (YoY)	+4.23%
Shares Change (QoQ)	-4.93%
Owned by Insiders (%)	10.19%
Owned by Institutions (%)	n/a
Float	90.96M

Valuation Ratios

The trailing PE ratio is 53.29.

PE Ratio	53.29
Forward PE	n/a
PS Ratio	1.18
PB Ratio	2.24
P/TBV Ratio	2.29
P/FCF Ratio	14.40
P/OCF Ratio	6.15
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.67, with an EV/FCF ratio of 12.36.

EV / Earnings	46.35
EV / Sales	1.01
EV / EBITDA	7.67
EV / EBIT	28.00
EV / FCF	12.36

Financial Position

The company has a current ratio of 2.62

Current Ratio	2.62
Quick Ratio	2.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.80% and return on invested capital (ROIC) is 4.92%.

Return on Equity (ROE)	4.80%
Return on Assets (ROA)	3.90%
Return on Invested Capital (ROIC)	4.92%
Return on Capital Employed (ROCE)	6.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	26
Asset Turnover	1.72
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.33% in the last 52 weeks. The beta is -1.86, so Avricore Health's price volatility has been lower than the market average.

Beta (5Y)	-1.86
52-Week Price Change	-63.33%
50-Day Moving Average	0.05
200-Day Moving Average	0.13
Relative Strength Index (RSI)	61.01
Average Volume (20 Days)	40,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of CAD 4.72 million and earned 103,128 in profits. Earnings per share was 0.00.

Revenue	4.72M
Gross Profit	1.79M
Operating Income	170,749
Pretax Income	103,128
Net Income	103,128
EBITDA	623,392
EBIT	170,749
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 790,515 in cash and n/a in debt, giving a net cash position of 790,515 or 0.01 per share.

Cash & Cash Equivalents	790,515
Total Debt	n/a
Net Cash	790,515
Net Cash Per Share	0.01
Equity (Book Value)	2.49M
Book Value Per Share	0.02
Working Capital	868,068

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 905,872 and capital expenditures -519,076, giving a free cash flow of 386,796.

Operating Cash Flow	905,872
Capital Expenditures	-519,076
Free Cash Flow	386,796
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 37.97%, with operating and profit margins of 3.62% and 2.19%.

Gross Margin	37.97%
Operating Margin	3.62%
Pretax Margin	2.19%
Profit Margin	2.19%
EBITDA Margin	13.21%
EBIT Margin	3.62%
FCF Margin	8.20%

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.23%
Shareholder Yield	-4.23%
Earnings Yield	1.85%
FCF Yield	6.94%

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Avricore Health has an Altman Z-Score of 7.31.

Altman Z-Score	7.31
Piotroski F-Score	n/a